CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
CCND2 | Cyclin D2 | Cancer-related genes
| | | | | Mixed |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes
| | | | | Mixed |
CCNG1 | Cyclin G1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CCNG2 | Cyclin G2 | Cancer-related genes
| | | | | Expressed in all |
CCNH | Cyclin H | Cancer-related genes
| | | | | Expressed in all |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes
| | | | | Mixed |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD46 | CD46 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD52 | CD52 molecule | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD70 | CD70 molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDC16 | Cell division cycle 16 | Cancer-related genes
| | | | | Expressed in all |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CDC25A | Cell division cycle 25A | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
CDC25B | Cell division cycle 25B | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CDC37 | Cell division cycle 37 | Cancer-related genes
| | | | | Expressed in all |
CDC6 | Cell division cycle 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK2 | Cyclin-dependent kinase 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDK4 | Cyclin-dependent kinase 4 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Cancer-related genes
| | | | | Expressed in all |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFLAR | CASP8 and FADD-like apoptosis regulator | Cancer-related genes Enzymes
| | | | | Expressed in all |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB | Chorionic gonadotropin, beta polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |